Nonstructural 3/4A protease of hepatitis C virus activates epithelial growth factor-induced signal transduction by cleavage of the T-cell protein tyrosine phosphatase-Reference-Cited by-同舟云学术

Nonstructural 3/4A protease of hepatitis C virus activates epithelial growth factor-induced signal transduction by cleavage of the T-cell protein tyrosine phosphatase

Published:2009-01-23 Issue:6 Volume:49 Page:1810-1820
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Brenndörfer Erwin Daniel,Karthe Juliane,Frelin Lars,Cebula Patricia,Erhardt Andreas,Schulte am Esch Jan,Hengel Hartmut,Bartenschlager Ralf,Sällberg Matti,Häussinger Dieter,Bode Johannes Georg

Publisher

Wiley

Subject

Hepatology

Reference27 articles.

1. Replication of hepatitis C virus;Moradpour;Nat Rev Microbiol,2007

2. Hepatitis C virus (HCV) employs multiple strategies to subvert the host innate antiviral response;Bode;Biol Chem,2008

3. The hepatitis C virus and immune evasion: non-structural 3/4A transgenic mice are resistant to lethal tumour necrosis factor {alpha} mediated liver disease;Frelin;Gut,2006

4. Host factors involved in the replication of hepatitis C virus;Moriishi;Rev Med Virol,2007

5. Subversion of cell signaling pathways by hepatitis C virus nonstructural 5A protein via interaction with Grb2 and P85 phosphatidylinositol 3-kinase;He;J Virol,2002

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From viruses to cancer: exploring the role of the hepatitis C virus NS3 protein in carcinogenesis;Infectious Agents and Cancer;2024-08-27

2. Role of hepcidin upregulation and proteolytic cleavage of ferroportin 1 in hepatitis C virus-induced iron accumulation;PLOS Pathogens;2023-08-16

3. Safety and Antiviral Activity of EGFR Inhibition by Erlotinib in Chronic Hepatitis C Patients: A Phase Ib Randomized Controlled Trial;Clinical and Translational Gastroenterology;2022-04-01

4. Role of mammalian target of rapamycin complex 2 in primary and secondary liver cancer;World Journal of Gastrointestinal Oncology;2021-11-15

5. EGF rs4444903 polymorphism is associated with risk of HCV-related cirrhosis and HBV/HCV-related hepatocellular carcinoma;International Journal of Clinical Oncology;2021-07-21